Skip to main content

Table 3 Laboratory measures

From: Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort

  T0 T6 Δ T0–T6
  All patients N C All patients N C All patients N C
HB, g/dl, mean ± SD 14.3 ± 1.3 14.3 ± 1.1 14.2 ± 1.4 14.4 ± 1.2 14.4 ± 1.1 14.4 ± 1.3 0.1 ± 0.9 0.1 ± 1 0.1 ± 0.8
WBC, 1/mm3, mean ± SD 6684.6 ± 1809.9 6681.9 ± 1722.3 6731.4 ± 1885 6911.2 ± 1750.7 6649.6 ± 1512.8 7106.3 ± 1897.3 226.5 ± 1505.4 227.7 ± 1347.8 374.9 ± 1607.5
PLT, 103/mm3, mean ± SD 267.5 ± 229.1 241.5 ± 59.2 287 ± 298 247.5 ± 65.2 239.2 ± 60.5 253.6 ± 68.2 −20.1 ± 225.5 −12.3 ± 34.4 −33.4 ± 296.8
CRP, mg/L, mean ± SD 3.4 ± 6.2 3.2 ± 3.9 3.7 ± 7.4 3.5 ± 5.6 2.6 ± 3.1 4.1 ± 6.9 0.1 ± 6.4 −0.1 ± 4 0.3 ± 7.7
ESR, mm/h, mean ± SD 15.2 ± 17.1 13.8 ± 14.4 16.3 ± 18.9 14.1 ± 13.6 11.6 ± 10.3 16 ± 15.5 −1.1 ± 13.1 −2.2 ± 9.7 −0.3 ± 15.2
Urate, mg/dl, mean ± SD 5.5 ± 1.1 5.4 ± 1 5.6 ± 1.3 4.8 ± 1.8 4.7 ± 2 4.9 ± 1.7 −0.5 ± 1.6 −0.1 ± 0.3 −0.7 ± 1.9
HbA1c, mmol/mol, mean ± SD*** 47.4 ± 15 52.5 ± 21.1 44 ± 9 59.6 ± 20.7 63.2 ± 26.1 57.7 ± 18.5 4.5 ± 13.3 7.3 ± 21.5 2.7 ± 5.6
FBG, mg/dl, mean ± SD* 105.1 ± 26.5 113.3 ± 30.4 100.9 ± 23.8 101.6 ± 27.2 98.9 ± 25 103.5 ± 28.9 2.4 ± 21.4 −7.4 ± 14.7 7.3 ± 22.9
LDL-c, mg/dl, mean ± SD 130.8 ± 36.5 132.3 ± 35 129.7 ± 38.4 130.6 ± 34.7 125.7 ± 34.8 134.4 ± 34.5 −1.2 ± 24.1 −5.2 ± 31.6 1.8 ± 16.7
HDL-c, mg/dl, mean ± SD** 54.7 ± 15.4 61.1 ± 17.5 49.8 ± 11.7 55.7 ± 17.5 59.2 ± 21.2 53 ± 13.6 0 ± 8 −1.1 ± 7.3 0.9 ± 8.5
TC, mg/dl, mean ± SD 209.7 ± 45.1 211.4 ± 41.2 208.5 ± 48.4 205.6 ± 37.2 204.9 ± 40.6 206.2 ± 34.6 2.1 ± 26 −0.1 ± 29.5 3.8 ± 23.3
Triglycerides, mg/dl, mean ± SD 123.2 ± 63.4 118.8 ± 57.3 127.4 ± 65.7 125.3 ± 57.8 115.5 ± 52.5 130.8 ± 60.6 2.5 ± 44 −3.3 ± 51.1 3.8 ± 38.1
TC/HDL-c ratio, mean ± SD 4 ± 1.4 3.8 ± 1.3 4.2 ± 1.4 4.1 ± 1.4 3.9 ± 1.3 4.3 ± 1.5 0.1 ± 0.5 0 ± 0.6 0.1 ± 0.4
GOT, U/L, mean ± SD 22.4 ± 8.7 23.1 ± 9.1 21.8 ± 8.5 23.1 ± 8.2 23.5 ± 8.6 22.9 ± 8 0.8 ± 8 0.4 ± 7.9 1 ± 8.2
GPT, U/L, mean ± SD 24.4 ± 15 24.7 ± 15.2 24.3 ± 15 25.1 ± 13.6 25.1 ± 12.6 25.1 ± 14.4 0.7 ± 13.1 0.4 ± 11.3 0.9 ± 14.3
GGT, U/L, mean ± SD 21.8 ± 19.1 23.7 ± 20.3 20.5 ± 18.1 23.5 ± 19.7 24.6 ± 23.4 22.7 ± 16.5 1.7 ± 20.2 1 ± 16.6 2.2 ± 22.5
Creatinine, mg/dl, mean ± SD 0.9 ± 0.2 0.9 ± 0.3 0.9 ± 0.2 1 ± 1.4 1.2 ± 2.1 0.8 ± 0.2 0.1 ± 1.3 0.3 ± 2 0 ± 0.1
TSH, μU/ml, mean ± SD 3.2 ± 2 2.9 ± 0.5 3.3 ± 2 3.5 ± 2.6 3.6 ± 3.6 3.4 ± 1.9 0.3w ± 3.7 0.5 ± 6.4 0.2 ± 0.4
  1. N nutritional group, C control group, HB hemoglobin, WBC white blood count, PLT platelets, ESR erythrocyte sedimentation rate, CRP C-reactive protein, HbA1c glycated hemoglobin, FBG fasting blood glucose, LDL-c low-density lipoprotein cholesterol, HDL-c high-density lipoprotein cholesterol, TC total cholesterol, GOT glutamic oxaloacetic transaminase, GPT glutamic pyruvic transaminase, GGT gamma-glutamyltransferase, TSH thyroid-stimulating hormone
  2. *A significative difference in the FBG levels was observed at T0 comparing the N and C (p = 0.039)
  3. **A significative difference in the HDL-c levels was observed at T0 comparing the N and C (p = 0.048)
  4. ***A significative change in HbA1c was observed at T6 in the N compared to C (p = 0.01)
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us